These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19667107)

  • 1. Inhibition of platelet-rich arterial thrombus in vivo: acute antithrombotic effect of intravenous HMG-CoA reductase therapy.
    Obi C; Wysokinski W; Karnicki K; Owen WG; McBane RD
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1271-6. PubMed ID: 19667107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis.
    Karnicki K; Leadley RJ; Baxi S; Peterson T; Wysokinski W; McBane RD
    Thromb Haemost; 2008 Apr; 99(4):759-66. PubMed ID: 18392334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of experimental carotid artery thrombosis by applaggin.
    Rote WE; Mu DX; Roncinske RA; Frelinger AL; Lucchesi BR
    J Pharmacol Exp Ther; 1993 Nov; 267(2):809-14. PubMed ID: 8246155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent arterial antithrombotic effect of direct factor-Xa inhibition with ZK-807834 administered to coronary artery disease patients.
    Zafar MU; Farkouh ME; Osende J; Shimbo D; Palencia S; Crook J; Leadley R; Fuster V; Chesebro JH
    Thromb Haemost; 2007 Mar; 97(3):487-92. PubMed ID: 17334518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets possess and require an active protein palmitoylation pathway for agonist-mediated activation and in vivo thrombus formation.
    Sim DS; Dilks JR; Flaumenhaft R
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1478-85. PubMed ID: 17303775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melagatran attenuates fibrin and platelet deposition in a porcine coronary artery over-stretch injury model.
    Scherstén F; Wahlund G; Björnheden T; Carlsson S; Mattsson C; Grip L
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):235-41. PubMed ID: 12695745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of high dose simvastatin on, platelet size in patients with, type 2 diabetes mellitus.
    Isley WL; Park Y; Harris WS
    Platelets; 2006 Aug; 17(5):292-5. PubMed ID: 16928600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of thrombosis by a novel platelet selective S-nitrosothiol compound without hemodynamic side effects.
    Vilahur G; Baldellou MI; Segalés E; Salas E; Badimon L
    Cardiovasc Res; 2004 Mar; 61(4):806-16. PubMed ID: 14985078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of lovastatin to bone and its effect on bone turnover in rats.
    Jadhav SB; Narayana Murthy PS; Singh MM; Jain GK
    J Pharm Pharmacol; 2006 Nov; 58(11):1451-8. PubMed ID: 17132207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition and reversal of platelet-rich arterial thrombus in vivo: direct vs. indirect factor Xa inhibition.
    Karnicki K; McBane RD; Miller RS; Leadley RJ; Morser J; Owen WG; Chesebro JH
    J Thromb Haemost; 2004 Dec; 2(12):2162-9. PubMed ID: 15613022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide augments venous and arterial thrombosis in the mouse.
    Wang X
    Thromb Res; 2008; 123(2):355-60. PubMed ID: 18448153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins in atherothrombosis.
    Colli S; Werba JP; Tremoli E
    Semin Vasc Med; 2004 Nov; 4(4):407-15. PubMed ID: 15861322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-thrombotic effect of proanthocyanidin, a purified ingredient of grape seed.
    Sano T; Oda E; Yamashita T; Naemura A; Ijiri Y; Yamakoshi J; Yamamoto J
    Thromb Res; 2005; 115(1-2):115-21. PubMed ID: 15567462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute arterial thrombosis in the absence of inflammation: the stress-related anti-inflammatory hormone ACTH participates in platelet-mediated thrombosis.
    Pozzi AO; Bernardo E; Coronado MT; Punchard MA; González P; Fantidis P
    Atherosclerosis; 2009 May; 204(1):79-84. PubMed ID: 18834983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disodium disuccinate astaxanthin prevents carotid artery rethrombosis and ex vivo platelet activation.
    Lauver DA; Driscoll EM; Lucchesi BR
    Pharmacology; 2008; 82(1):67-73. PubMed ID: 18477858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local delivery of soluble platelet collagen receptor glycoprotein VI inhibits thrombus formation in vivo.
    Bültmann A; Herdeg C; Li Z; Münch G; Baumgartner C; Langer H; Kremmer E; Geisler T; May A; Ungerer M; Gawaz M
    Thromb Haemost; 2006 May; 95(5):763-6. PubMed ID: 16676064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intimatan (dermatan 4,6-O-disulfate) prevents rethrombosis after successful thrombolysis in the canine model of deep vessel wall injury.
    Hong TT; Van Gorp CL; Cardin AD; Lucchesi BR
    Thromb Res; 2006; 117(3):333-42. PubMed ID: 15893368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porcine model of stent thrombosis: platelets are the primary component of acute stent closure.
    Jeong MH; Owen WG; Staab ME; Srivatsa SS; Sangiorgi G; Stewart M; Holmes DR; Schwartz RS
    Cathet Cardiovasc Diagn; 1996 May; 38(1):38-43. PubMed ID: 8722856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversibility of platelet thrombosis in vivo. Quantitative analysis in porcine carotid arteries.
    Wysokinski W; McBane R; Chesebro JH; Owen WG
    Thromb Haemost; 1996 Dec; 76(6):1108-13. PubMed ID: 8972039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous prostacyclin decreases vasoconstriction but not platelet thrombus deposition after arterial injury.
    Lam JY; Chesebro JH; Badimon L; Fuster V
    J Am Coll Cardiol; 1993 Feb; 21(2):488-92. PubMed ID: 8426015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.